Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06743373 · ClinicalTrials.gov registry record · NA
Cannabis Effects on Sleep, Circadian Rhythms, and Light Sensitivity in Young Adults
A NA study of Sleep and Cannabis Use, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT06743373: Recruiting NA study of Sleep and Cannabis Use, sponsored by University of Pittsburgh.
NCT06743373 is a NA study of Sleep and Cannabis Use that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 180 participants, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06743373, a NA study of Sleep and Cannabis Use, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to learn how cannabis use and discontinuation affect sleep, circadian rhythms, and sensitivity to light. The main questions it aims to answer are: 1. Does cannabis use and discontinuation impact sleep drive? 2. Does cannabis use and discontinuation impact light sensitivity and circadian phase?
Primary Outcome
Rate of slow wave activity dissipation, assessed by at-home EEG headband. Compared within person (cannabis-using days vs. non using days), between groups (Cannabis-Using, Control) at Baseline, and within-group (Cannabis-Using) between Baseline and Post-discontinuation.
Conditions Studied
Interventions
- BEHAVIORAL Cannabis Discontinuation
Study Locations (1)
Pennsylvania
- Western Psychiatric Hospital (Thomas Detre Hall) - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2025-03-13 |
| Est. Completion | 2029-04-30 |
| Phase | NA |
What NCT06743373 shows while recruiting
NCT06743373 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Sleep appearing as the primary indexed condition, and to 1 intervention - of which Cannabis Discontinuation is the first listed.
NCT06743373 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06743373 about?
NCT06743373 is a clinical study titled "Cannabis Effects on Sleep, Circadian Rhythms, and Light Sensitivity in Young Adults". The goal of this study is to learn how cannabis use and discontinuation affect sleep, circadian rhythms, and sensitivity to light. The main questions it aims to answer are: 1. Does cannabis use and discontinuation impact sleep drive? 2. Does cannabis use and discontinuation impact light sensitivity...
What is the current status of trial NCT06743373?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2025-03-13. Estimated completion is 2029-04-30.
What conditions does trial NCT06743373 study?
This clinical trial studies the following conditions: Sleep, Cannabis Use, Circadian Rhythm.
What interventions are being tested in trial NCT06743373?
The interventions under investigation include: Cannabis Discontinuation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06743373?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06743373 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06743373's enrollment target sits among peer trials
180 34th of 151 higher than 116 of 151 other Sleep trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
The Effects of Sleep on Human Microbiota: Implications for Health and Disease
RECRUITING · NA
-
The Goodnight Screen Media Study
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Shifting Sleep Timing in Teens
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI